Chronic Obstructive Pulmonary Disease

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

Overview

Feature Articles

Latest Chronic Obstructive Pulmonary Disease News and Research

Scientists uncover genetics involved in COVID-19 induced respiratory failure

Scientists uncover genetics involved in COVID-19 induced respiratory failure

Budesonide’s antiviral effect against SARS-CoV-2

Budesonide’s antiviral effect against SARS-CoV-2

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

Adults with ADHD at higher risk of many physical conditions, finds study

Adults with ADHD at higher risk of many physical conditions, finds study

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Inhibiting necroptosis could be a novel approach for treating COPD

Inhibiting necroptosis could be a novel approach for treating COPD

Chronic fatigue a significant challenge for most long COVID patients

Chronic fatigue a significant challenge for most long COVID patients

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Long COVID patients at higher risk of small airway disease

Long COVID patients at higher risk of small airway disease

Study shows CoronaVac to have high seroconversion rate after 40 days

Study shows CoronaVac to have high seroconversion rate after 40 days

Shared genetic architecture between COVID-19 severity and other health conditions

Shared genetic architecture between COVID-19 severity and other health conditions

Scientists discover novel defensive response to SARS-CoV-2

Scientists discover novel defensive response to SARS-CoV-2

As pandemic eases, many seniors have lost strength, may need rehabilitative services

As pandemic eases, many seniors have lost strength, may need rehabilitative services

Facets of SARS-CoV-2 infection and animal models

Facets of SARS-CoV-2 infection and animal models

About two-fifths of Medicare beneficiaries with COPD have limited access to pulmonary rehabilitation services

About two-fifths of Medicare beneficiaries with COPD have limited access to pulmonary rehabilitation services

UB pharmacy researcher to design real-time algorithm to reduce hospital readmission rates for COPD patients

UB pharmacy researcher to design real-time algorithm to reduce hospital readmission rates for COPD patients